Tradestie Institutional Equity Comparison Engine
KBA vs KURE โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
KURE Overall Edge
KURE Captures Institutional Edge (2โ0 Pillars ยท 2โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to KraneShares MSCI All China Health Care Index ETF (KURE) driven by superior Momentum & Technical, Options & Structure. Fundamentally, KBA trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus KURE at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, KBA sits in UNCLASSIFIED (23rd %ile IV; Dealer Gamma Walls on Pro) against KURE sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
KBA N/M vs KURE N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
KURE
1Y -9.1% vs -9.4% ยท 52W Pos 0% vs 62%
Options & Structure Winner
KURE
UNCLASSIFIED (23rd %ile IV) vs UNCLASSIFIED (<1st %ile IV)
KBA
NYSE Arca
KraneShares Bosera MSCI China A 50 Connect Index ETF
Institutional Equity
$27.83
-1.14% 1D
Market Cap
N/A
1M Return
-5.66%
1Y Return
-9.14%
Forward P/E
N/M
Unified AI Score
44.0 / 100
HOLD
Tech 38.0
Fund 51.0
Flow 50.0
Mom 60.0
KURE
NYSE Arca
KraneShares MSCI All China Health Care Index ETF
Institutional Equity
$17.81
-1.66% 1D
Market Cap
N/A
1M Return
+0.91%
1Y Return
-9.36%
Forward P/E
N/M
Unified AI Score
50.9 / 100
HOLD
Tech 44.0
Fund 48.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
KBA -9.14%
KURE -9.36%
Spread: +0.22 pp (KBA Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
KBA TTM Op. Margin: N/A
KURE TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on KBA vs KURE. Trailing 12-month operating profitability (KBA N/A vs KURE N/A) and valuation multiples (KBA N/M vs KURE N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | KBA | KURE | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 0% ($28โ$35) | 62% ($14โ$20) | Stronger Trend | KURE |
| Beta / 30D Volatility Risk Regime | 0.85ฮฒ ยท 19% Vol | 0.73ฮฒ ยท 32% Vol | Lower Realized Risk | KBA |
| Unified Institutional Score Composite Signal | 44.0 / 100 (HOLD) | 50.9 / 100 (HOLD) | Higher Composite | KURE |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full KBA vs KURE Buy Guide
KBA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
23rd %ile
IV Regime
Compressed (<25th %ile)
KURE
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
<1st %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither KBA nor KURE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.